Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model

Authors: Blommestein, Hedwig M. ^{a, ⁎}, de Groot, Saskia ^{a, b}, Leeneman, Brenda ^{a, b}, Uyl-de Groot, Carin A. ^{a, b}, Haanen, John B.A.G. ^c, Wouters, Michel W.J.M. ^{d, e, f}, Aarts, Maureen J.B. ^g, van den Berkmortel, Franchette W.P.J. ^h, Blokx, Willeke A.M. ⁱ, Boers-Sonderen, Marye J. ^j, van den Eertwegh, Alfons J.M. ^k, de Groot, Jan Willem B. ^l, Hospers, Geke A.P. ^m, Kapiteijn, Ellen ⁿ, van Not, Olivier J. ^{d, o}, van der Veldt, Astrid A.M. ^p, Suijkerbuijk, Karijn P.M. ^o, Franken, Margreet G. ^{a, b, 1}

Source: In European Journal of Cancer 11 March 2025 218

Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Authors: Kennedy, Oliver John ^{a, b, ⁎, 1}, Glassee, Nina ^{c, 1}, Kicinski, Michal ^c, Bührer, Emanuel ^c, Valpione, Sara ^d, Gandini, Sara ^e, Suciu, Stefan ^c, Blank, Christian U. ^f, Long, Georgina V. ^g, Atkinson, Victoria G. ^h, Dalle, Stéphane ⁱ, Haydon, Andrew M. ^j, Meshcheryakov, Andrey ^k, Khattak, Adnan ^l, Carlino, Matteo S. ^m, Sandhu, Shahneen ⁿ, Larkin, James ^o, Puig, Susana ^p, Ascierto, Paolo A. ^q, Rutkowski, Piotr ^r, Schadendorf, Dirk ^s, Boers-Sonderen, Marye ^t, Di Giacomo, Anna Maria ^u, van den Eertwegh, Alfonsus J.M. ^v, Grob, Jean-Jacques ^w, Gutzmer, Ralf ^x, Jamal, Rahima ^y, van Akkooi, Alexander C.J. ^z, Robert, Caroline ^aa, Eggermont, Alexander M.M. ^{ab, ac}, Lorigan, Paul ^{a, b, 2}, Mandala, Mario ^{ad, 2}

Source: In EJC Skin Cancer 2025 3

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial

Authors: Eggermont, Alexander MM, Kicinski, Michal, Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Meshcheryakov, Andrey, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Boers-Sonderen, Marye, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus JM, Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, van Akkooi, Alexander C.J., Lorigan, Paul, Grebennik, Dmitri, Kreplere, Clemens, Marreaud, Sandrine, Suciu, Stefan, Robert, Caroline

Source: In European Journal of Cancer November 2024 211

Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma

Authors: van Duin, Isabella A.J., Schuiveling, Mark, ter Maat, Laurens S., van Amsterdam, Wouter A.C., van den Berkmortel, Franchette, Boers-Sonderen, Marye, de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Labots, Mariette, Piersma, Djura, Schrader, Anne M.R., Vreugdenhil, Gerard, Westgeest, Hans, Veta, Mitko, Blokx, Willeke A.M., van Diest, Paul J., Suijkerbuijk, Karijn P.M.

Source: In European Journal of Cancer September 2024 208

Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma

Authors: Verheijden, Rik J., Burgers, Femke H., Janssen, Josephine C., Putker, Anouk E., Veenstra, Sophie P.G.R., Hospers, Geke A.P., Aarts, Maureen J.B., Hehenkamp, Karel W., Doornebosch, Veerle L.E., Verhaert, Marthe, van den Berkmortel, Franchette W.P.J., Chatzidionysiou, Katerina, Llobell, Arturo, Barros, Milton, Maria, Alexandre T.J., Takeji, Akari, García Morillo, José-Salvador, Lidar, Merav, van Eijs, Mick J.M., Blank, Christian U., Aspeslagh, Sandrine, Piersma, Djura, Kapiteijn, Ellen, Labots, Mariette, Boers-Sonderen, Marye J., van der Veldt, Astrid A.M., Haanen, John B.A.G., May, Anne M., Suijkerbuijk, Karijn P.M.

Source: In European Journal of Cancer August 2024 207

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Authors: Kennedy, Oliver John, Glassee, Nina, Kicinski, Michal, Blank, Christian U., Long, Georgina V., Atkinson, Victoria G., Dalle, Stéphane, Haydon, Andrew M., Meshcheryakov, Andrey, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Boers-Sonderen, Marye, Giacomo, Anna Maria Di, van den Eertwegh, Alfonsus J.M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, van Akkooi, Alexander C.J., Gandini, Sara, Buhrer, Emanuel, Suciu, Stefan, Robert, Caroline, Eggermont, Alexander M.M., Mandala, Mario, Lorigan, Paul, Valpione, Sara

Source: In European Journal of Cancer April 2024 201

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021

Authors: van Not, Olivier J., van den Eertwegh, Alfons J.M., Haanen, John B., Blank, Christian U., Aarts, Maureen J.B., van Breeschoten, Jesper, van den Berkmortel, Franchette W.P.J., de Groot, Jan-Willem B., Hospers, Geke A.P., Ismail, Rawa K., Kapiteijn, Ellen, Bloem, Manja, De Meza, Melissa M., Piersma, Djura, van Rijn, Rozemarijn S., Stevense-den Boer, Marion A.M., van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Boers-Sonderen, Marye J., Blokx, Willeke A.M., Wouters, Michel W.J.M., Suijkerbuijk, Karijn P.M.

Source: In eClinicalMedicine March 2024 69

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma

Authors: ter Maat, Laurens S., van Duin, Isabella A.J., Elias, Sjoerd G., Leiner, Tim, Verhoeff, Joost J.C., Arntz, Eran R.A.N., Troenokarso, Max F., Blokx, Willeke A.M., Isgum, Ivana, de Wit, Geraldine A., van den Berkmortel, Franchette W.P.J., Boers-Sonderen, Marye J., Boomsma, Martijn F., van den Eertwegh, Fons J.M., de Groot, Jan Willem B., Piersma, Djura, Vreugdenhil, Art, Westgeest, Hans M., Kapiteijn, Ellen, van Diest, Paul J., Pluim, Josien P.W., de Jong, Pim A., Suijkerbuijk, Karijn P.M., Veta, Mitko

Source: European journal of cancer. 185:167-177

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100196123725.0x000001&indx=1&recIds=ETOCvdc_100196123725.0x000001

Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

Authors: Van Not, Olivier J., van den Eertwegh, Alfons J.M., Haanen, John B., van Rijn, Rozemarijn S., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., Blank, Christian U., Boers-Sonderen, Marye J., van Eijs, Mick J.M., de Groot, Jan-Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, de Meza, Melissa, Piersma, Djura, Stevense-den Boer, Marion, van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Wouters, Michel W.J.M., Suijkerbuijk, Karijn P.M., Blokx, Willeke A.M.

Source: European journal of cancer. 186:27-37

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194198354.0x000001&indx=1&recIds=ETOCvdc_100194198354.0x000001

Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands

Authors: van Zeijl, Michiel C.T., van Breeschoten, Jesper, de Wreede, Liesbeth C., Wouters, Michel W.J.M., Hilarius, Doranne L., Blank, Christian U., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Stevense-den Boer, Marion A., van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Boers-Sonderen, Marye J., Suijkerbuijk, Karijn P.M., Haanen, John B.A.G., van den Eertwegh, Alfons J.M.

Source: Journal of immunotherapy. 46(5):197-204

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190870420.0x000001&indx=1&recIds=ETOCvdc_100190870420.0x000001

Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry

Authors: van Breeschoten, Jesper, van den Eertwegh, Alfons J.M., Hilarius, Doranne L., Haanen, John B., Blank, Christian U., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Stevense-den Boer, Marion A., van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Boers-Sonderen, Marye J., Manevski, Damjan, Suijkerbuijk, Karijn P.M., Wouters, Michel W.J.M., de Wreede, Liesbeth C.

Source: European journal of cancer. 182:132-143

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183940787.0x000001&indx=1&recIds=ETOCvdc_100183940787.0x000001

Adjuvant treatment of in‐transit melanoma: Narrowing the knowledge gap left by clinical trials

Authors: Meza, Melissa M., Blokx, Willeke A. M., Bonenkamp, Han J., Blank, Cristian U., Aarts, Maureen J. B., Berkmortel, Franchette W. P. J., Boers‐Sonderen, Marye J., Groot, Jan Willem B., Haanen, John B., Hospers, Geke A. P., Kapiteijn, Ellen W., Not, Olivier J., Piersma, Djura, Rijn, Rozemarijn S., Stevense‐Den Boer, Marion A., Veldt, Astrid A. M., Vreugdenhil, Gerard, Eertwegh, Alfons J. M., Suijkerbuijk, Karijn P. M., Wouters, Michel W. J. M.

Source: International journal of cancer. 153(2):389-398

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182474656.0x000001&indx=1&recIds=ETOCvdc_100182474656.0x000001

Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma

Authors: Duin, Isabella A. J., Elias, Sjoerd G., Eertwegh, Alfonsus J. M., Groot, Jan Willem B., Blokx, Willeke A. M., Diest, Paul J., Leiner, Tim, Verhoeff, Joost J. C., Verheijden, Rik J., Not, Olivier J., Aarts, Maureen J. B., Berkmortel, Franchette W. P. J., Blank, Christian U., Haanen, John B. A. G., Hospers, Geke A. P., Kamphuis, Anna M., Piersma, Djura, Rijn, Rozemarijn S., Veldt, Astrid A. M., Vreugdenhil, Gerard, Wouters, Michel W. J. M., Stevense‐den Boer, Marion A. M., Boers‐Sonderen, Marye J., Kapiteijn, Ellen, Suijkerbuijk, Karijn P. M.

Source: International journal of cancer. 152(12):2493-2502

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182124321.0x000001&indx=1&recIds=ETOCvdc_100182124321.0x000001

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Authors: Kennedy, Oliver John, Kicinski, Michal, Valpione, Sara, Gandini, Sara, Suciu, Stefan, Blank, Christian U., Long, Georgina V., Atkinson, Victoria G., Dalle, Stéphane, Haydon, Andrew M., Meshcheryakov, Andrey, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Boers-Sonderen, Marye, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J.M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, van Akkooi, Alexander C.J., Robert, Caroline, Eggermont, Alexander M.M., Lorigan, Paul, Mandala, Mario

Source: In European Journal of Cancer August 2023 189

Kidney Injury in Patients Treated with Immune Checkpoint Inhibitors Does Not Meet KDIGO-AKI Criteria

Authors: Verploegen, Maartje F.A., Boers-Sonderen, Marye J., Piet, Berber, Wetzels, Jack F.M.

Source: Kidney360. 3(3):524-529

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100188582827.0x000001&indx=1&recIds=ETOCvdc_100188582827.0x000001

The unfavorable effects of COVID‐19 on Dutch advanced melanoma care

Authors: Not, Olivier J., Breeschoten, Jesper, Eertwegh, Alfonsus J. M., Hilarius, Doranne L., De Meza, Melissa M., Haanen, John B., Blank, Christian U., Aarts, Maureen J. B., Berkmortel, Franchette W. P. J., Groot, Jan Willem B., Hospers, Geke A. P., Ismail, Rawa K., Kapiteijn, Ellen, Piersma, Djura, Rijn, Rozemarijn S., Stevense‐den Boer, Marion A. M., Veldt, Astrid A. M., Vreugdenhil, Gerard, Boers‐Sonderen, Marye J., Blokx, Willeke A. M., Suijkerbuijk, Karijn P. M., Wouters, Michel W. J. M.

Source: International journal of cancer. 150(5):816-824

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187488743.0x000001&indx=1&recIds=ETOCvdc_100187488743.0x000001

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study

Authors: van Breeschoten, Jesper, Ismail, Rawa K., Wouters, Michel W.J.M., Hilarius, Doranne L., de Wreede, Liesbeth C., Haanen, John B., Blank, Christian U., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Stevense-den Boer, Marion A., van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Boers-Sonderen, Marye J., Suijkerbuijk, Karijn P.M., van den Eertwegh, Alfons J.M.

Source: JCO oncology practice. 18(10):e1611-e1620

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177476530.0x000001&indx=1&recIds=ETOCvdc_100177476530.0x000001

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors

Authors: Ismail, Rawa K., Suijkerbuijk, Karijn P.M., de Boer, Anthonius, van Dartel, Maaike, Hilarius, Doranne L., Pasmooij, A.M.G., van Zeijl, Michiel C.T., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., Blank, Christian U., Boers-Sonderen, Marye J., de Groot, Jan W.B., Haanen, John B.A.G., Hospers, Geke A.P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., van der Veldt, Astrid A.M., Vreugdenhil, Art, Westgeest, Hans, van den Eertwegh, Alfons J., Wouters, Michel W.J.M.

Source: Melanoma research. 32(6):460-468

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172934137.0x000001&indx=1&recIds=ETOCvdc_100172934137.0x000001

Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study

Authors: van Not, Olivier J., de Meza, Melissa M., van den Eertwegh, Alfons J.M., Haanen, John B., Blank, Christian U., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., van Breeschoten, Jesper, de Groot, Jan-Willem B., Hospers, Geke A.P., Ismail, Rawa K., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Roos S., Stevense-den Boer, Marion A.M., van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Bonenkamp, Han J., Boers-Sonderen, Marye J., Blokx, Willeke A.M., Wouters, Michel W.J.M., Suijkerbuijk, Karijn P.M.

Source: European journal of cancer. 167:70-80

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161514763.0x000001&indx=1&recIds=ETOCvdc_100161514763.0x000001

Adjuvant treatment for melanoma in clinical practice – Trial versus reality

Authors: de Meza, Melissa M., Ismail, Rawa K., Rauwerdink, Daan, van Not, Olivier J., van Breeschoten, Jesper, Blokx, Willeke A.M., de Boer, Anthonius, van Dartel, Maaike, Hilarius, Doranne L., Ellebaek, Eva, Bonenkamp, Han J., Blank, Christian U., Aarts, Maureen J.B., van Akkooi, Alexander C.J., van den Berkmortel, Franchette W.P.J., Boers-Sonderen, Marye J., de Groot, Jan Willem B., Haanen, John B., Hospers, Geke A.P., Kapiteijn, Ellen W., Piersma, Djura, van Rijn, Roos S., van der Veldt, Astrid A.M., Vreugdenhil, Art, Westgeest, Hans M., van den Eertwegh, Alfons J.M., Suijkerbuijk, Karijn P.M., Wouters, Michel W.J.M.

Source: In European Journal of Cancer November 2021 158:234-245